Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - OtherRevenue (Gross)
Ratios

Abeona Therapeutics (ABEO) Receivables - Net: 2011-2023

Historic Receivables - Net for Abeona Therapeutics (ABEO) over the last 9 years, with Jun 2023 value amounting to $3.5 million.

  • Abeona Therapeutics' Receivables - Net rose 87.27% to $3.5 million in Q2 2023 from the same period last year, while for Jun 2023 it was $3.5 million, marking a year-over-year increase of 87.27%. This contributed to the annual value of $3.0 million for FY2021, which is N/A change from last year.
  • As of Q2 2023, Abeona Therapeutics' Receivables - Net stood at $3.5 million, which was up 234.29% from $1.0 million recorded in Q3 2022.
  • Abeona Therapeutics' Receivables - Net's 5-year high stood at $7.0 million during Q3 2020, with a 5-year trough of $15,000 in Q3 2019.
  • In the last 3 years, Abeona Therapeutics' Receivables - Net had a median value of $2.4 million in 2021 and averaged $2.4 million.
  • Its Receivables - Net has fluctuated over the past 5 years, first tumbled by 99.89% in 2019, then spiked by 46,566.67% in 2020.
  • Over the past 5 years, Abeona Therapeutics' Receivables - Net (Quarterly) stood at $15,000 in 2019, then skyrocketed by 46,566.67% to $7.0 million in 2020, then reached $3.0 million in 2021, then reached $1.0 million in 2022, then spiked by 87.27% to $3.5 million in 2023.
  • Its Receivables - Net was $3.5 million in Q2 2023, compared to $1.0 million in Q3 2022 and $1.9 million in Q2 2022.